takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
Tadataka Yamada M.D.
Chief Medical & Scientific Officer and Director, Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 128 board members in 7 different organizations across 11 different industries.|
See Board Relationships
Dr. Tadataka Yamada, also known as Tachi, M.D., has been Corporate Officer and Head of Emerging Markets Commercial Operations for Nycomed A/S at Takeda Pharmaceutical Company Limited. Dr. Yamada served as an Executive Vice President and Medical and Scientific Advisor to the Chief Executive Officer of Takeda Pharmaceutical Company Limited. Dr. Yamada serves as an Executive Vice President and Medical and Scientific Advisor to the CEO at Takeda Pharmaceuticals International ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*
Former Director and Member of Audit Coommittee
Executive Vice President, Medical & Scientific Advisor to the Chief Executive Officer and Director
Former Chairman of Research & Development, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Financial Results Committee
Former Director, Member of Compliance Committee and Member of Nominating & Governance Committee
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
Chief Medical & Scientific Officer and Director
The Leland Stanford Junior University
New York University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Vincent A. Forlenza BD||Chairman, Chief Executive Officer and President|
Becton, Dickinson and Company
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Karl-Ludwig Kley||Chairman of Executive Board|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year 2013.|